Monheim / Rhein, 8 May 2024. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company specializing in Single Pill combinations in the German market, has reported a profitable first quarter of 2024 due to a lower cost base and higher revenues of Single Pill combinations.
New development partnership with Apontis Pharma
APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a single pill with pan